CLINICAL AND MORPHOLOGICAL FEATURES OF GASTRIC CANCER IN PATIENTS OF THE PRIMORSKY KRAI
Main Article Content
Abstract
Gastric cancer remains one of the most significant problems in oncology, ranking fifth in incidence and third in mortality worldwide. This article analyzes the features of gastric cancer in the Primorsky Krai, where the reported incidence rate reaches 23.7 cases per 100,000 population.
The aim of the study – to characterize the pathomorphological features of gastric malignancies taking into account age-related characteristics.
Materials and methods. A retrospective study was performed from January to December 2022, including analysis of 62 medical records of patients with gastric cancer treated at the Medical Center of the Far Eastern Federal University. The mean age of the patients was 62.8 ± 10.4 years. The sample consisted of 41 men (66.1%) and 21 women (33.9%).
Results. It was found that the majority of patients had a history of metabolic disorders such as overweight and type 2 diabetes mellitus. The most frequent localization of the tumor process was the gastric cardia. Tumor sizes and disease stages were found to differ significantly depending on patient age. Intraoperative complications were more frequently recorded in elderly patients.
Conclusion. The obtained results confirm the need to take into account age-related features in the diagnosis and choice of treatment tactics for gastric cancer.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
1. Margusheva AA, Shibzukhov AS. A rare case of gastric cancer metastases to the colon. Literature review, clinical case description. National Association of Scientists. 2024; (102-103): 51-56. Russian (Маргушева А.А., Шибзухов А.С. Редкий случай метастазирования рака желудка в толстую кишку. Обзор литературы, описание клинического случая //Национальная ассоциация ученых. 2024. № 102-103. С. 51-56.)
2. Avgustinovich AV, Afanasyev SG, Dobrodeev AYu, Volkov MYu, Kostromitsky DN, Spirina LV, Cheremisina ОV. Short-term effcacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer. Siberian Journal of Oncology. 2022; 21(1): 11-19. Russian (Августинович А.В., Афанасьев С.Г., Добродеев А.Ю., Волков М.Ю., Костромицкий Д.Н., Спирина Л.В., Черемисина О.В. Непосредственная эффективность и токсичность тотальной неоадъювантной химиотерапии резектабельного рака желудка //Сибирский онкологический журнал. 2022. Т. 21, № 1. С. 11-19.) doi: 10.21294/1814-4861-2022-21-1-11-19
3. Kovalenko SA, Gladyshev DV, Moiseev ME, Vetoshkin VA, Svitich VYu, Gnedash SS. Immediate results of robot-assisted surgical interventions for gastric cancer. Russian Medical Inquiry. 2023; 7(6): 353-358. Russian (Коваленко С.А., Гладышев Д.В., Моисеев М.Е., Ветошкин В.А., Свитич В.Ю., Гнедаш С.С. Непосредственные результаты робот-ассистированных оперативных вмешательств при раке желудка //РМЖ. Медицинское обозрение. 2023. Т. 7, № 6. С. 353-358.) doi: 10.32364/2587-6821-2023-7-6-3
4. Kuznetsov KO, Safina ER, Gaimakova DV, Frolova YaS, Oganesyan IYu, Sadertdinova AG, et al. Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice. Problems of Endocrinology. 2022; 68(5): 45-55. Russian (Кузнецов К.О., Сафина Э.Р., Гаймакова Д.В., Фролова Я.С., Оганесян И.Ю., Садертдинова А.Г., и др. Метформин и злокачественные новообразования: возможный механизм противоопухолевого действия и перспективы использования в практике //Проблемы эндокринологии. 2022. Т. 68, № 5. С. 45-55.) doi: 10.14341/probl13097
5. Skoropad VYu, Kudriavtsev DD, Shitareva VN, Zhavoronkovа ES. Clinical case of pathological complete response of gastric cancer after one cycle of neoadjuvant chemotherapy with fot regimen. Siberian Journal of Oncology. 2022; 21(6): 164-169. Russian (Скоропад В.Ю., Кудрявцев Д.Д., Шитарева В.Н., Жаворонкова Е.С. Полный лечебный патоморфоз рака желудка после одного цикла неоадъювантной химиотерапии по схеме FLOT (клиническое наблюдение) //Сибирский онкологический журнал. 2022. Т. 21, № 6. С. 164-169.) doi: 10.21294/1814-4861-2022-21-6-164-169
6. Kaprin AD, Starinskiy VV, Shakhzadova AO, eds. Zlokachestvennye novoobrazovaniya v Rossii v 2023 godu. Moscow: MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii, 2024. 276 p. Russian (Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.). Злокачественные новообразования в России в 2023 году. Москва: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. 276 с)
7. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022; 28(12): 1187-1203. doi: 10.3748/wjg.v28.i12.1187
8. Gordienko VP. Stomach cancer on the territory of the Far Eastern Federal District. Pacific Medical Journal. 2020; (4): 49-54. Russian (Гордиенко В.П. Рак желудка на территории Дальневосточного федерального округа //Тихоокеанский медицинский журнал. 2020. № 4. С. 49-54.) doi: 10.34215/1609-1175-2020-4-49-54
9. López MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023; 181: 103841. doi: 10.1016/j.critrevonc.2022.103841
10. Andreev DN, Kucheravy YA. Obesity as a risk factor for diseases of the digestive system. Therapeutic archive. 2021; 93(8): 954-962. Russian (Андреев Д.Н., Кучерявый Ю.А. Ожирение как фактор риска заболеваний пищеварительной системы //Терапевтический архив. 2021. № 8. С. 954-962.) doi: 10.26442/00403660.2021.08.200983
11. Nenartovich IA. Ketogenic diet realities and prospects in clinical practice. Lechebnoe Delo. 2021; 1(76): 66-72. Russian (Ненартович И.А. Реалии и перспективы кетогенной диеты в клинической практике //Лечебное дело. 2021. № 1(76). С. 66-72.)
12. Guo J, Liu K, Pan J, Yang J. Relationship between diabetes and the risk of gastric cancer: a systematic review and meta-analysis of cohort studies. Diabetes Research and Clinical Practice. 2022; 187: 109866. doi: 10.1016/j.diabres.2022.109866
13. Dauletnazarov NK, Vyazovichenko YE, Torchinsky NV. Review of Controllable Risk Factors for the Development of Malignant Neoplasms of the Digestive Organs. Epidemiology and Vaccinal Prevention. 2025; 24(1): 90-100. Russian (Даулетназаров Н.К., Вязовиченко Ю.Е., Торчинский Н.В. Обзор управляемых факторов риска развития злокачественных новообразований органов пищеварения //Эпидемиология и вакцинопрофилактика. 2025. Т. 24, № 1. С. 90-100.) doi: 10.31631/2073-3046-2025-24-1-90-100
14. Pliszka M, Szablewski L. Links between diabetes mellitus and specific types of cancer. International Journal of Molecular Sciences. 2024; 25(13): 7476. doi: 10.3390/ijms25137476